Sartorius (OTCMKTS:SARTF) Short Interest Down 62.7% in July

Sartorius (OTCMKTS:SARTF) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totaling 915 shares, a decrease of 62.7% from the June 30th total of 2,451 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Sartorius Stock Performance

OTCMKTS SARTF opened at $212.80 on Monday. Sartorius has a twelve month low of $181.58 and a twelve month high of $227.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The stock has a market cap of $7.28 billion, a price-to-earnings ratio of 98.98 and a beta of 0.98. The firm’s 50 day moving average price is $211.27 and its two-hundred day moving average price is $219.86.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.